XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2025
STOCK-BASED COMPENSATION [Abstract]  
STOCK-BASED COMPENSATION
7.  STOCK-BASED COMPENSATION

Equity Incentive Plan
The 2019 Equity Incentive Plan (“Plan”) was approved by the Company’s Board of Directors on January 16, 2019 and by its shareholders on March 6, 2019. The purpose of the Plan is to: (i) attract and retain the best available personnel for positions of substantial responsibility, (ii) provide additional incentive to employees, directors and consultants, and (iii) promote the success of the Company’s business. The Plan permits the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, performance shares, and other stock-based awards. The maximum aggregate number of shares of common stock that may be issued pursuant to all awards under the Plan was 5,413,184 at March 31, 2025. The maximum aggregate number of shares that may be issued under the Plan may be increased annually by up to 3% of the total issued and outstanding common shares of the Company at the beginning of each fiscal year.

The fair value of each option award is estimated on the date of grant using the Black-Scholes model that uses the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock and similar peer company averages. The Company uses historical data to estimate option exercise and post-vesting termination behavior. The expected term of options granted represents the period of time that options granted are expected to be outstanding, which takes in to account that the options are not transferable. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

Options
A summary of activity in the Plan during the period indicated is presented in the table below (dollars in thousands, except per share data):


 
Number
of Shares
   
Weighted-Average
Exercise Price
 
Weighted-Average
Remaining
Contractual
Life in Years
   
Aggregate
Intrinsic Value
 
Three Months Ended March 312025
                     
Outstanding at beginning of year:
   
1,175,787
 
$
17.83
     
$
17,975
Granted
   
30,024
   
34.01
       
Exercised
   
(29,211
)
   
18.68
     
(422
)
Forfeited
   
   
       
Expired
   
   
       
                       
Balance at end of period
   
1,176,600
 
$
18.22
     
4.52
 
$
17,553
                           
Exercisable at end of period
   
1,091,254
 
$
17.26
     
4.19
 
$
17,302
                             
Vested at end of period
   
1,091,254
 
$
17.26
     
4.19
 
$
17,302

A summary of assumptions used to calculate the fair values of the awards granted during the periods noted is presented below:

 
Three Months Ended
March 31,
 
 
2025
   
2024
 
Expected volatility
   
41.21
%
   
40.45
%
Expected dividend yield
   
1.80
%
   
1.80
%
Expected term (years)
   
6.1
     
6.1
 
Risk-free interest rate
   
4.43
%
   
3.94
%
Weighted average grant date fair value
  $
13.35
    $
11.10
 

The total intrinsic value of options exercised during the three months ended March 31, 2025 and 2024 was $459 thousand and $26 thousand, respectively.

Restricted Stock Awards and Units
A summary of activity in the Plan during the period indicated is presented in the table below:

 
Number
of Shares
   
Weighted-Average
Grant Date
Fair Value
 
Three Months Ended March 312025
           
Outstanding at beginning of year:
   
187,895
   
$
26.51
 
Granted
   
70,700
     
34.24
 
Vested
   
(15,384
)
   
28.79
 
Forfeited
   
   
 
                 
Balance at end of period
   
243,211
   
$
28.61
 

Restricted stock units granted under the Plan typically vest from one to four years, but vesting periods may vary. Compensation expense for these grants will be recognized over the vesting period of the awards based on the fair value of the stock at the issue date. The total fair value of restricted stock units vested during each of the three months ended March 31, 2025 and 2024 was $443 thousand and $543 thousand, respectively.

For the three months ended March 31, 2025 and 2024 the Company recorded stock-based compensation expense related to the Plan of $536 thousand and $481 thousand, respectively.  The total unrecognized compensation cost for the awards outstanding under the Plan at March 31, 2025 was $5.5 million and will be recognized over a weighted average remaining period of 1.86 years.